Skip to content

Effect of remote ischemic preconditioning on cerebral oxygen saturation and neurocognitive function in elderly patients undergoing hip replacement

Effect of remote ischemic preconditioning on cerebral oxygen saturation and neurocognitive function in elderly patients undergoing hip replacement

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045612
Enrollment
Unknown
Registered
2021-04-19
Start date
2021-04-22
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Replacement

Interventions

Group E:RIPC after induction
Group L:RIPC 24 hours before surgery
Group T:RIPC 24 hours before surgery and after induction
Control group:Cuff is not inflated

Sponsors

The First People's Hospital of Lianyungang
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 65-80 years; 2. Patients undergoing elective hip replacement surgery; 3. The ASA score I-III, BMI 18-24 kg/m^2; 4. No obvious abnormalities in heart, lung, liver and kidney functions; 5. Clear understanding and volunteer to participate in this study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient has severe vision and hearing impairment, or other reasons cannot communicate with the visitor; 2. Patients with degenerative diseases of the central nervous system; 3. Patients who have undergone heart or central nervous system surgery, or LVEF < 50%; 4. Limb movement disorders that affect neurocognitive function assessment; 5. The score of the Mini-Mental State Scale (MMSE) before operation cannot be matched and is lower than the minimum score of the corresponding education level (literacy <= 17 points, primary school <= 20 points, secondary school <=22 points, university <= 23 points); 6. Alcohol dependent patients; 7. Peripheral vascular disease (especially the stenosis or occlusion of the subclavian artery and upper extremity artery) or neurological disease affecting the sensory function of the upper extremity; 8. Patients with abnormal blood coagulation function; 9. Patients with difficulty in tracheal intubation; 10. Taking sedatives or antidepressants; 11. Withdrawal midway Experimenter.

Design outcomes

Primary

MeasureTime frame
Regional cerebral oxygen saturation;

Secondary

MeasureTime frame
Incidence of delirium;Neuron specific enolase;Brain fatty acid binding protein;

Countries

China

Contacts

Public ContactChen Ying

The First People's Hospital of Lianyungang

chy366@163.com+86 18961322003

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026